Navigation
Municipal Commission of Health and Family Planning and Municipal Food and Drug Administration Held an Meeting of the Supervision and Inspection of Clinical Stem Cells Research and Filing Agencies
From:Beijing Municipal Commission of Health and Family Planning
Date:03/05/2018

 

On January 16, the Municipal Commission of Health and Family Planning and the Municipal Food and Drug Administration held an on-the-spot meeting on the supervision and inspection of clinical trials of stem cells and working meeting of filing agencies to carry out a specialized supervision and inspection of the progress of the recorded project of stem cells clinical research of Fuwai Hospital of Chinese Academy of Medical Sciences. 12 hospitals in Beijing area were organized to discussed the filing agencies of clinical research of stem cells announced by the National Health and Family Planning Commission and the National Food and Drug Administration.

Experts of stem cells clinical research from the Municipal Commission of Health and Family Planning and the Municipal Food and Drug Administration formed a supervision group to listen to the report on the recorded project progress of stem cells clinical research of Fu Wai Hospital. They conducted major inspection of related work of stem cells clinical research like staffing, organizational management, preparation management and research management. The inspection group pointed out that we must continue to improve personnel, conditions and management system to ensure an order and standard clinical research on stem cells.

Wu Shuxia, Deputy Director of the Information Center of Institute of Medical Information of the Academy of Military Medical Sciences, introduced the latest progress of stem cells clinical research both at home and abroad. Yuan Baozhu, Director of Cells Resource Storage and Research Center of China Institute for Food and Drug Control, introduced key points of quality evaluation of clinical research of medical institutions. Filing agencies in Beijing area on stem cells clinical research reported respectively on organizational management, system construction and proposed filing of projects and exchanged ideas and discussed practical problems of clinical research on stem cells with the experts.

Zheng Jinpu, Deputy Inspector of Municipal Commission of Health and Family Planning attended the meeting. He proposed specific requirements on the strict control of quality of clinical research on stem cells, improvement the mechanism of protection of rights and interests of subjects, and effective control of risks and other aspects.